News|Articles|November 3, 2025

ASN Kidney Week 2025 Preview: 5 Phase 3 Trials to Know

Kidney Week 2025 showcases groundbreaking clinical trials and FDA approvals, marking a transformative era in nephrology and kidney disease treatment.

When American Society of Nephrology (ASN) Kidney Week 2025 convenes in Houston, Texas, from November 5-9, it will do so at a pivotal time for the field. For decades, progress in nephrology was measured in slow, incremental gains. However, the last decade has brought forth evidence of shifting momentum, with decades of foundational research translating into meaningful clinical advances across diseases once defined by limited options.

Related to this article

September 22nd, 2026

How the ASN's GD-C Compendium Aims to Unify Glomerular Disease Care

George Vasquez-Rios, MD, explains how the ASN's GD-C Compendium curates glomerular disease guidance for general clinicians and specialists alike.

September 25th, 2026

The Case for Routine Kidney Screening, With Pranav Garimella, MBBS, MPH

Pranav Garimella discusses what a potential USPSTF kidney screening recommendation could mean for high-risk adults and primary care.

September 24th, 2026

Nearly 9 in 10 US Adults With CKD Don't Know They Have It, With Pranav Garimella

As the USPSTF considers evidence for updated CKD screening guidance, Garimella discusses gaps in kidney disease detection and what the review should capture.